Skip to main content

Bone/OP&OA

Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau

Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Methotrexate and Prednisone for Hand OA: Dr. Paul Sufka

Dr. Sufka discusses abstracts #1759 and #1760 at the 2019 ACR/ARP annual meeting in Atlanta. 

Bad to the Bone: Dr. Chad Deal

Dr. Deal highlights the session 'Bad to the Bone: Metabolic Bone Disease" at the 2019 ACR/ARP Annual Meeting in Atlanta. 

The Great Debate: Dr. Chad Deal

Dr. Deal highlights The Great Debate: Anabolic Agents Are/Are Not Appropriate First-Line Therapy for Glucocorticoid-Induced Osteoporosis, and offers his opinion on this debate at the 2019 ACR/ARP Annual Meeting in Atlanta. 

×